FR2900155B1 - Hydrolisat de cartilage aviaire, procede d'obtention et utilisations - Google Patents
Hydrolisat de cartilage aviaire, procede d'obtention et utilisationsInfo
- Publication number
- FR2900155B1 FR2900155B1 FR0603547A FR0603547A FR2900155B1 FR 2900155 B1 FR2900155 B1 FR 2900155B1 FR 0603547 A FR0603547 A FR 0603547A FR 0603547 A FR0603547 A FR 0603547A FR 2900155 B1 FR2900155 B1 FR 2900155B1
- Authority
- FR
- France
- Prior art keywords
- cartilage
- hydrolyzate
- reaction mixture
- avian
- hydroxyproline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000000845 cartilage Anatomy 0.000 title abstract 5
- 241000271566 Aves Species 0.000 title abstract 3
- 239000011541 reaction mixture Substances 0.000 abstract 3
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 abstract 2
- 102000035195 Peptidases Human genes 0.000 abstract 2
- 108091005804 Peptidases Proteins 0.000 abstract 2
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 abstract 2
- 229960002591 hydroxyproline Drugs 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000002994 raw material Substances 0.000 abstract 2
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 abstract 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 abstract 1
- 229920001287 Chondroitin sulfate Polymers 0.000 abstract 1
- 102000000503 Collagen Type II Human genes 0.000 abstract 1
- 108010041390 Collagen Type II Proteins 0.000 abstract 1
- LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Natural products NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 abstract 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 abstract 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 abstract 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 abstract 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 abstract 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
- 239000004472 Lysine Substances 0.000 abstract 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 abstract 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 abstract 1
- 229940024606 amino acid Drugs 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 229940059329 chondroitin sulfate Drugs 0.000 abstract 1
- YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical compound NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 229920002674 hyaluronan Polymers 0.000 abstract 1
- 229960003160 hyaluronic acid Drugs 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Natural products NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 abstract 1
- 230000000415 inactivating effect Effects 0.000 abstract 1
- 229960000310 isoleucine Drugs 0.000 abstract 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000001954 sterilising effect Effects 0.000 abstract 1
- 210000001562 sternum Anatomy 0.000 abstract 1
- 239000004474 valine Substances 0.000 abstract 1
- -1 valine (2.7-3.3%) Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/10—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from hair, feathers, horn, skins, leather, bones, or the like
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0603547A FR2900155B1 (fr) | 2006-04-21 | 2006-04-21 | Hydrolisat de cartilage aviaire, procede d'obtention et utilisations |
US11/455,239 US7671041B2 (en) | 2006-04-21 | 2006-06-19 | Hydrolysate of avian cartilage, process of preparation and uses thereof |
AT07728309T ATE459371T1 (de) | 2006-04-21 | 2007-04-19 | Hydrolysat von vogelknorpel, verfahren zu seiner herstellung und seine verwendungen |
DE602007005115T DE602007005115D1 (de) | 2006-04-21 | 2007-04-19 | Hydrolysat von vogelknorpel, verfahren zu seiner herstellung und seine verwendungen |
PCT/EP2007/053850 WO2007122179A1 (fr) | 2006-04-21 | 2007-04-19 | Hydrolysat de cartilage avien, procédé de préparation et utilisation |
EP07728309A EP2012818B1 (fr) | 2006-04-21 | 2007-04-19 | Hydrolysat de cartilage avien, procédé de préparation et utilisation |
ES07728309T ES2341497T3 (es) | 2006-04-21 | 2007-04-19 | Hidrolizado de cartilago aviar, procedimiento de preparacion y sus usos. |
JP2009505896A JP4947475B2 (ja) | 2006-04-21 | 2007-04-19 | 鳥軟骨の水解物並びにその調製方法及び使用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0603547A FR2900155B1 (fr) | 2006-04-21 | 2006-04-21 | Hydrolisat de cartilage aviaire, procede d'obtention et utilisations |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2900155A1 FR2900155A1 (fr) | 2007-10-26 |
FR2900155B1 true FR2900155B1 (fr) | 2008-06-27 |
Family
ID=37307203
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0603547A Expired - Fee Related FR2900155B1 (fr) | 2006-04-21 | 2006-04-21 | Hydrolisat de cartilage aviaire, procede d'obtention et utilisations |
Country Status (6)
Country | Link |
---|---|
US (1) | US7671041B2 (fr) |
JP (1) | JP4947475B2 (fr) |
AT (1) | ATE459371T1 (fr) |
DE (1) | DE602007005115D1 (fr) |
ES (1) | ES2341497T3 (fr) |
FR (1) | FR2900155B1 (fr) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101629517B1 (ko) * | 2007-06-01 | 2016-06-13 | 교와 핫꼬 바이오 가부시키가이샤 | 경구 조성물 |
CN101779733B (zh) * | 2010-03-29 | 2012-12-26 | 济南环亿生物科技有限公司 | 一种提高畜禽肌肉中胶原蛋白的饲料添加剂及其生产方法和应用 |
DE102010060564A1 (de) * | 2010-11-15 | 2012-05-16 | Gelita Ag | Verwendung von Kollagenhydrolysat zur Verbesserung der Gesundheit der menschlichen Haut, Haare und/oder Nägel |
ES2403804B1 (es) * | 2011-09-21 | 2014-07-15 | Bioib�Rica, S.A. | Producto de cartílago. |
WO2012143324A1 (fr) | 2011-04-19 | 2012-10-26 | Bioiberica, S.A. | Produit de cartilage |
CN102690372B (zh) * | 2012-05-16 | 2014-04-23 | 中国农业科学院农产品加工研究所 | 一种鸡骨架联产脱骨原料肉、鸡骨高汤及硫酸软骨素的方法 |
EP2900808B1 (fr) | 2012-09-28 | 2019-04-03 | Scripps Health | Procédés de différenciation de cellules souches en chondrocytes |
JP6324395B2 (ja) | 2012-10-29 | 2018-05-16 | スクリップス ヘルス | 軟骨細胞を移植する方法 |
JP6399558B2 (ja) | 2012-10-29 | 2018-10-03 | スクリップス ヘルス | 軟骨細胞から多能性幹細胞を製造する方法 |
US11478504B2 (en) | 2013-07-08 | 2022-10-25 | International Dehydrated Foods, Inc. | Compositions and methods for preventing/treating metabolic syndrome |
JP2016523966A (ja) | 2013-07-08 | 2016-08-12 | インターナショナル ディハイドレーティッド フーズ, インコーポレイテッド | 家禽から調製した組成物およびその使用方法 |
AU2014202041B8 (en) * | 2013-10-24 | 2020-04-02 | Lonza Greenwood Llc | Method of reducing exercise-induced joint pain in non-arthritic mammals |
WO2017165281A1 (fr) | 2016-03-22 | 2017-09-28 | Avicenna Nutraceutical, Llc | Compositions de collagène hydrolysé et leurs procédés de fabrication |
US11702447B2 (en) | 2017-05-11 | 2023-07-18 | Avicenna Nutraceutical, Inc. | Methods for producing collagen |
BR112020004053A2 (pt) * | 2017-08-31 | 2020-09-01 | Lonza Llc | composição de promoção da saúde e métodos de uso de suplementos |
US20190100785A1 (en) * | 2017-10-03 | 2019-04-04 | Robert den Hoed | Method of producing undenatured collagen from cartilage with low temperature hydrolysis |
JP2023508934A (ja) * | 2019-12-27 | 2023-03-06 | サントリーホールディングス株式会社 | 環状ジペプチド、プリンヌクレオチド及び/又はアミノ酸とチキンエキスとを含む組成物、その製造方法、並びに、環状ジペプチド、プリンヌクレオチド及び/又はアミノ酸、並びにチキンエキスの使用 |
CN115151140A (zh) * | 2019-12-27 | 2022-10-04 | 三得利控股株式会社 | 含有肽和/或其盐的食品或饮料组合物、其生产方法、经水解的ii型胶原的用途、抑制骨吸收的组合物以及鸡提取物的用途 |
WO2021131104A1 (fr) * | 2019-12-27 | 2021-07-01 | Suntory Holdings Limited | Composition contenant un peptide, son procédé de production et utilisation du peptide |
WO2023213909A1 (fr) | 2022-05-04 | 2023-11-09 | Rousselot Bv | Composition d'hydrolysat de collagène pour réduire des douleurs articulaires après un exercice |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6025327A (en) * | 1997-08-08 | 2000-02-15 | Biocell Technology, Llc | Hydrolyzed collagen type II and use thereof |
US6780841B2 (en) * | 2001-11-13 | 2004-08-24 | Biocell Technology, Llc | Hyaluronic acid and chondroitin sulfate based hydrolyzed collagen type II and method of making same |
JP4436084B2 (ja) * | 2003-08-04 | 2010-03-24 | 日本メナード化粧品株式会社 | コラーゲン産生促進剤及びコラーゲン架橋形成阻害剤 |
WO2005014622A2 (fr) * | 2003-08-07 | 2005-02-17 | F. Hoffmann-La Roche Ag | Peptides antigeniques de l'arthrite rhumatoide |
AU2004272066B8 (en) * | 2003-09-11 | 2010-08-05 | Genentech, Inc. | Methods of using WISP antagonists |
EP1709171A2 (fr) * | 2003-11-06 | 2006-10-11 | Novartis AG | Clonage et caracterisation de regions flanquantes 5' d'un gene d'aggrecanase-1 humain |
JP2005314265A (ja) * | 2004-04-28 | 2005-11-10 | Nippon Menaade Keshohin Kk | 老化防止剤 |
-
2006
- 2006-04-21 FR FR0603547A patent/FR2900155B1/fr not_active Expired - Fee Related
- 2006-06-19 US US11/455,239 patent/US7671041B2/en active Active
-
2007
- 2007-04-19 JP JP2009505896A patent/JP4947475B2/ja active Active
- 2007-04-19 DE DE602007005115T patent/DE602007005115D1/de active Active
- 2007-04-19 ES ES07728309T patent/ES2341497T3/es active Active
- 2007-04-19 AT AT07728309T patent/ATE459371T1/de active
Also Published As
Publication number | Publication date |
---|---|
DE602007005115D1 (de) | 2010-04-15 |
US20070293427A1 (en) | 2007-12-20 |
ES2341497T3 (es) | 2010-06-21 |
ATE459371T1 (de) | 2010-03-15 |
JP2009536923A (ja) | 2009-10-22 |
FR2900155A1 (fr) | 2007-10-26 |
US7671041B2 (en) | 2010-03-02 |
JP4947475B2 (ja) | 2012-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2900155B1 (fr) | Hydrolisat de cartilage aviaire, procede d'obtention et utilisations | |
Mochizuki et al. | Laminin‐1 peptide‐conjugated chitosan membranes as a novel approach for cell engineering | |
Feng et al. | Transepithelial transport efficiency of bovine collagen hydrolysates in a human Caco-2 cell line model | |
UA89616C2 (ru) | Гидролизат казеина, способ его получения и применения | |
CN107630060B (zh) | 自组装胶原蛋白及其制备方法 | |
CN100369929C (zh) | 海蜇胶原蛋白及其制备方法 | |
CN1555393A (zh) | 角蛋白基产品及其生产方法 | |
WO2009142441A3 (fr) | Procédé de production d'hydrolysat de gluten de maïs et hydrolysat de gluten de maïs l'utilisant | |
US20100286368A1 (en) | Novel polypeptide and process for producing the same | |
CN102676620B (zh) | 一种高分子量鱿鱼皮胶原蛋白的制备方法 | |
Heck et al. | Enzyme‐catalyzed formation of β‐peptides: β‐peptidyl aminopeptidases BapA and DmpA acting as β‐peptide‐synthesizing enzymes | |
DE60314526D1 (de) | Modifizierte lupinproteine zur herstellung einer wasser-dispergierbaren produktform fettlöslicher stoffe | |
CN107630059B (zh) | 新型自组装胶原蛋白及制备方法 | |
CN1927435A (zh) | 去除甲醛的材料 | |
CN107630058B (zh) | 一种新型自组装胶原蛋白及制备方法 | |
Li et al. | Effective biodegradation on chicken feather by the recombinant KerJY-23 Bacillus subtilis WB600: A synergistic process coupled by disulfide reductase and keratinase | |
CN105602481A (zh) | 一种本体型高强度仿生粘合剂的制备方法 | |
KR20040108147A (ko) | 어류 비늘을 이용한 단백질 가수분해물의 제조방법 | |
CN1958781A (zh) | 一种试剂蛋白胨及其制备方法 | |
WO2007059874A3 (fr) | Compositions pour traiter l'arthrose et nourrir le liquide synovial | |
NZ603012A (en) | Preparation of polypeptides and salts thereof | |
CN105920675A (zh) | 一种制备生物功能化壳聚糖水凝胶的方法 | |
CN1712516A (zh) | 一种蛋白胨及其制备方法 | |
CA3056759C (fr) | Compositions de collagene hydrolyse et leurs procedes de fabrication | |
BRPI0805852A8 (pt) | polímeros ácidos protéicos, processos de produção, uso de polímeros ácidos protéicos, composição farmacêutica e método de tratamento |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 11 |
|
PLFP | Fee payment |
Year of fee payment: 12 |
|
PLFP | Fee payment |
Year of fee payment: 13 |
|
PLFP | Fee payment |
Year of fee payment: 14 |
|
PLFP | Fee payment |
Year of fee payment: 15 |
|
PLFP | Fee payment |
Year of fee payment: 16 |
|
CA | Change of address |
Effective date: 20211203 |
|
CD | Change of name or company name |
Owner name: DIANA FOOD, FR Effective date: 20211203 |
|
ST | Notification of lapse |
Effective date: 20221205 |